Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

  1. Home
  2. /Competitive
  3. /Company Moves

Competitive

Company Moves(4)

Monitor how competitors respond to market openings, data releases, and regulatory milestones across key franchises.

4 signals

ScoreIntelligence Record
8.0

COMPETITIVE

Roche Launches First Fully Automated HDV Test to Enhance Diagnosis and Monitoring

Roche has introduced the cobas HDV test, the first fully automated diagnostic solution for Hepatitis D Virus, enhancing diagnosis and treatment monitoring.

Roche·July 14, 2026
8.0

COMPETITIVE

Roche Launches AXELIOS 1 Next-Generation Sequencing Platform

Roche has launched the AXELIOS 1 platform, a next-generation sequencing solution that offers high accuracy, speed, and cost efficiency.

Roche·June 29, 2026
8.0

COMPETITIVE

Roche Launches AXELIOS 1 Next-Generation Sequencing Platform

Roche has launched AXELIOS 1, a next-generation sequencing platform utilizing innovative SBX technology for rapid and accurate whole-genome sequencing.

Roche·June 29, 2026
8.0

COMPETITIVE

Roche Launches Liver Disease Panel to Enhance Chronic Liver Disease Management

Roche has launched the Liver Disease Panel, a suite of certified algorithms aimed at improving the management of chronic liver disease (CLD). This panel includes the LiverPRO algorithm, which facilitates early detection of liver fibrosis using routine blood markers.

Roche·Hepatology·June 16, 2026

Showing 1–4 of 4 records

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.